161 results on '"Fereidoonnezhad, Masood"'
Search Results
2. Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine
3. Exploring Anticancer Potential: Synthesis and Assessment of the Biological Activity of Novel Synthesized Pyrazinoic Acid Derivatives
4. Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents
5. Synthesis and biological evaluations of novel pyrazinoic acid derivatives as anticancer agents
6. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
7. Design, synthesis, molecular docking, biological evaluations and QSAR studies of novel dichloroacetate analogues as anticancer agent
8. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate
9. Design, Synthesis, Molecular Docking and Biological Activity of New Piperidine and Piperazine Derivatives of Dichloroacetate as Potential Anticancer Agents
10. In vitro and in silico anticancer activity of amygdalin on the SK-BR-3 human breast cancer cell line
11. Synthesis, cytotoxicity, apoptosis and molecular docking studies of novel phenylbutyrate derivatives as potential anticancer agents
12. Alignment-independent 3D-QSAR and molecular docking studies of tacrine−4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents
13. Luminescent Heterobimetallic PtII–AuI Complexes Bearing N-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
14. Effects of Diphosphine Ligands on the Anticancer Behavior of Cycloplatinated(II) Complexes of 2,2´-Bipyridine N-Oxide: In vitro cytotoxicity, Apoptosis, Genotoxicity, and Molecular Docking Studies
15. A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors
16. Synthesis of N‐(2‐(tert‐Butylamino)‐2‐oxoethyl)‐2,2‐dichloro‐N‐aryl(alkyl)acetamides as Anticancer Agents: Molecular Modeling and Biological Evaluations
17. Synthesis of a half-sandwich complex of ruthenium(ii) with a nonsymmetric bis-nitrogen donor ligand: biological investigations
18. Binuclear platinum(ii) complexes bearing various bridging 1,1′-diphosphinoferrocene ligands as potential anticancer agents: synthesis and biological evaluation
19. The binding of small carbazole derivative (P7C3) to protofibrils of the Alzheimer’s disease and β-secretase: Molecular dynamics simulation studies
20. Luminescent Heterobimetallic PtII–AuI Complexes Bearing N‑Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents.
21. ROS‐Mediated Antitumor Activity, Apoptosis, and Molecular Docking Studies of Platinum(II) Coordination Complexes Bearing 2‐(Diphenylphosphino)pyridine Ligands.
22. ROS-mediated antitumor activity, apoptosis, and molecular docking studies of platinum (II) coordination complexes bearing 2-(diphenylphosphino)pyridine ligand
23. Luminescent Heterobimetallic PtII–AuIComplexes Bearing N-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
24. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations
25. Additional file 1 of Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents
26. Reproductive Toxicity of Cassia Absus Seeds in Female Rats: Possible Progesteronic Properties of Chaksine and b-Sitosterol
27. Half-Sandwich Cyclometalated RhIII Complexes Bearing Thiolate Ligands: Biomolecular Interactions and In Vitro and In Vivo Evaluations
28. Synthesis, and Biological Evaluations of Novel Pyrazinoic Acid Derivatives as Anticancer Agents
29. Autophagy Effects of Fluorinated Cycloplatinated(II) Complex Bearing Dppm Ligand on Cancer Cells in In-Vitro Culture and In-Silico Prediction
30. Fluorinated Cycloplatinated(II) Complexes Bearing Bisphosphine Ligands as Potent Anticancer Agents
31. An efficient nano-biocatalyst for lignocellulosic biomass hydrolysis: Xylanase immobilization on organically modified biogenic mesoporous silica nanoparticles
32. Half-Sandwich Cyclometalated RhIII Complexes Bearing Thiolate Ligands: Biomolecular Interactions and In Vitro and In Vivo Evaluations.
33. Half-Lantern Cyclometalated Platinum(II) Complexes as Potent Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis and Cytotoxic Activity Evaluations
34. Half-Sandwich Cyclometalated RhIIIComplexes Bearing Thiolate Ligands: Biomolecular Interactions and In Vitroand In VivoEvaluations
35. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: MolecularDocking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations
36. trans‐Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents
37. Heterobimetallic Pt II ‐Au I Complexes Comprising Unsymmetrical 1,1‐Bis(diphenylphosphanyl)methane Bridges: Synthesis, Photophysical, and Cytotoxic Studies
38. Synthesis and biological evaluation of thiolate gold(i) complexes as thioredoxin reductase (TrxR) and glutathione reductase (GR) inhibitors
39. Metal–Organic Frameworks and Covalent Organic Frameworks as Platforms for Photodynamic Therapy
40. Fluorinated Cycloplatinated(II) Complexes Bearing Bisphosphine Ligands as Potent Anticancer Agents.
41. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate.
42. Synthesis, Molecular Docking and Cytotoxic Activity Evaluation of Organometallic Thiolated Gold(I) Complexes.
43. Design, synthesis, molecular docking and cytotoxic activity evaluations of novel piperidine and piperazine derivatives of dichloroacetate as potential anticancer agents.
44. Cover Image
45. (Benzyl isocyanide)gold(I) pyrimidine‐2‐thiolate complex: Synthesis and biological activity
46. Cycloplatinated(ii) complexes bearing 1,1′-bis(diphenylphosphino)ferrocene ligand: biological evaluation and molecular docking studies
47. Synthesis, structural characterization, biological evaluation and molecular docking studies of new platinum(ii) complexes containing isocyanides
48. Cycloplatinated(ii) complexes bearing an O,S-heterocyclic ligand: search for anticancer drugs
49. An in-depth investigation on the C–I bond activation by rollover cycloplatinated(ii) complexes bearing monodentate phosphane ligands: kinetic and kinetic isotope effect
50. Molecular Docking and PLIF Studies of Novel Tacrine-Naphtoquinone Hybrids Based on Multi-Target-Directed Ligand Approach for Alzheimer’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.